go figure, page-9

Thanks Justin, I missed that. (must have fallen asleep during he b'room radio).

I was actually referring to FDA Approval for the Recell product (s). I would think that Recell is the key to any serious growth in share price and the VSG products will keep it afloat until that happens. Another 2-3 years before it can really kicks off I think? A simplistic view probably.

Despite there being a massive market for inhalers (& delivery systems of whatever type) it ain't unique. It must be an incredibly competitive market and difficult to crack.

Back to work for me!